Ingen internetforbindelse — viser den gemte version af siden.
← til store investorer

SR One Capital Management, LP

institutionel investor · portefølje $1.04 mia. · 15 positioner · rapport pr. 30.06.2026

Aktiepositioner rapport for 30.06.2026, indsendt 12.08.2026; ændring — mod 31.03.2026 · 17

SelskabAktierVærdi% af porteføljenÆndring i kvartalet
Veradermics, Incorporated
US:MANE
2 401 868$295 mio.28.42%—
Zenas BioPharma, Inc.
US:ZBIO
5 037 854$128 mio.12.31%—
CRISPR Therapeutics AG
CUSIP H17182108
2 038 763$111 mio.10.70%—
Avalyn Pharma Inc.
US:AVLN
3 308 649$109 mio.10.48%ny
Design Therapeutics Inc
US:DSGN
6 526 476$94.4 mio.9.09%—
Odyssey Therapeutics, Inc.
US:ODTX
3 794 883$71.0 mio.6.83%ny
Alumis Inc
US:ALMS
1 959 896$55.2 mio.5.31%—
Oric Pharmaceuticals, Inc.
US:ORIC
4 615 384$50.0 mio.4.81%+100 455
Mineralys Therapeutics, Inc.
US:MLYS
1 563 966$42.2 mio.4.06%—
ARS Pharmaceuticals, Inc
US:SPRY
4 012 903$32.1 mio.3.09%—
Mobia Medical, Inc.
US:MOBI
1 986 072$26.6 mio.2.56%ny
Nkarta Inc
US:NKTX
3 333 333$9.43 mio.0.91%—
Oculis Holding AG
CUSIP H5870P102
641 022$8.89 mio.0.86%—
Ultragenyx
US:RARE
137 753$4.60 mio.0.44%—
enGene Holdings Inc.
CUSIP 29286M105
747 750$1.29 mio.0.12%—
Arcellx, Inc.
CUSIP 03940C100
0 (var 2 346 630)——solgt
Oruka Therapeutics, Inc.
US:ORKA
0 (var 430 330)——solgt

I virksomheder i vores database 11

SelskabAndelAktierRapportdato
Design Therapeutics Inc10.43%6 526 4762026-06-30
Odyssey Therapeutics, Inc.7.89%3 794 8832026-06-30
Avalyn Pharma Inc.7.46%3 308 6492026-06-30
Zenas BioPharma, Inc.7.43%5 037 8542026-06-30
Mobia Medical, Inc.5.97%1 986 0722026-06-30
Veradermics, Incorporated5.75%2 401 8682026-06-30
Nkarta Inc4.65%3 333 3332026-06-30
ARS Pharmaceuticals, Inc4.04%4 012 9032026-06-30
CRISPR Therapeutics AG2.11%2 038 7632026-06-30
Oculis Holding AG1.11%641 0222026-06-30
ADARx Pharmaceuticals, Inc.——2026-09-28
annonce